nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0686	0.248	CbGeAlD
Remoxipride—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0667	0.241	CbGeAlD
Remoxipride—DRD4—heart—dilated cardiomyopathy	0.0478	0.172	CbGeAlD
Remoxipride—SIGMAR1—cardiac ventricle—dilated cardiomyopathy	0.0268	0.0967	CbGeAlD
Remoxipride—SIGMAR1—myocardium—dilated cardiomyopathy	0.0252	0.0909	CbGeAlD
Remoxipride—SIGMAR1—heart—dilated cardiomyopathy	0.0176	0.0635	CbGeAlD
Remoxipride—SIGMAR1—cardiac atrium—dilated cardiomyopathy	0.015	0.0543	CbGeAlD
Remoxipride—DRD2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0137	0.0189	CbGpPWpGaD
Remoxipride—HTR2A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0135	0.0186	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0126	0.0175	CbGpPWpGaD
Remoxipride—DRD3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0122	0.0168	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0115	0.0159	CbGpPWpGaD
Remoxipride—DRD2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0115	0.0159	CbGpPWpGaD
Remoxipride—HTR2A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0113	0.0156	CbGpPWpGaD
Remoxipride—DRD2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0111	0.0153	CbGpPWpGaD
Remoxipride—HTR2A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0109	0.0151	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0103	0.0142	CbGpPWpGaD
Remoxipride—HTR2A—heart—dilated cardiomyopathy	0.00937	0.0338	CbGeAlD
Remoxipride—DRD2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00932	0.0129	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00923	0.0128	CbGpPWpGaD
Remoxipride—HTR2A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00917	0.0127	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00912	0.0126	CbGpPWpGaD
Remoxipride—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00885	0.0122	CbGpPWpGaD
Remoxipride—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RAF1—dilated cardiomyopathy	0.00838	0.0116	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00821	0.0114	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0082	0.0113	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00724	0.01	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00698	0.00966	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00687	0.0095	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00643	0.0089	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00617	0.00854	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00484	0.0067	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00465	0.00643	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00465	0.00643	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00432	0.00598	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00431	0.00597	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00413	0.00571	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00413	0.00571	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00401	0.00555	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00388	0.00537	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00384	0.00531	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00383	0.0053	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0037	0.00511	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0037	0.00511	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00356	0.00493	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00345	0.00477	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00344	0.00475	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00333	0.0046	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00332	0.00459	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00328	0.00454	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00328	0.00454	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00321	0.00443	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00316	0.00437	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00316	0.00437	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00315	0.00435	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00305	0.00422	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00304	0.00421	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00296	0.00409	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00295	0.00407	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00294	0.00406	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00293	0.00405	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00288	0.00399	CbGpPWpGaD
Remoxipride—HTR2A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00287	0.00397	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00284	0.00393	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00281	0.00389	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00281	0.00389	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00279	0.00387	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00278	0.00385	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00273	0.00377	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.0027	0.00374	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0027	0.00373	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00268	0.00371	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00264	0.00365	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00262	0.00362	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0026	0.00359	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00257	0.00355	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00253	0.0035	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00252	0.00349	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00251	0.00348	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00251	0.00347	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00251	0.00347	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0025	0.00346	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0025	0.00346	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00247	0.00342	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00247	0.00342	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00239	0.00331	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00234	0.00323	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00232	0.00321	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0023	0.00318	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00226	0.00313	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00225	0.00312	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00225	0.00311	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00223	0.00309	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00223	0.00308	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00222	0.00307	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00216	0.00299	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00214	0.00296	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0021	0.00291	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00207	0.00286	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00205	0.00284	CbGpPWpGaD
Remoxipride—HTR2A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00202	0.00279	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.002	0.00277	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00193	0.00267	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00192	0.00266	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00191	0.00265	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00191	0.00265	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0019	0.00263	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00188	0.0026	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00188	0.0026	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00183	0.00253	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00182	0.00252	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00181	0.0025	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0018	0.00249	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00178	0.00246	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00178	0.00246	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00175	0.00242	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00172	0.00238	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00171	0.00236	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00169	0.00234	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00159	0.0022	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00159	0.0022	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00152	0.00211	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00148	0.00204	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00147	0.00203	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00145	0.002	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00144	0.002	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00144	0.002	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00143	0.00198	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00141	0.00195	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00141	0.00195	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.0014	0.00193	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00137	0.0019	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00136	0.00188	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00135	0.00187	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00134	0.00186	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00134	0.00185	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00131	0.00182	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0013	0.0018	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00128	0.00177	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00128	0.00177	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00127	0.00176	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00125	0.00173	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00122	0.00169	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00119	0.00165	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00116	0.0016	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00115	0.0016	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00111	0.00154	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00109	0.0015	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00108	0.0015	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00108	0.0015	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.00108	0.00149	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00106	0.00147	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00106	0.00147	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00106	0.00146	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00105	0.00146	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00103	0.00143	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00103	0.00143	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00102	0.00141	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.00102	0.00141	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.001	0.00139	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000989	0.00137	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000986	0.00136	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000982	0.00136	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000982	0.00136	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000973	0.00135	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000966	0.00134	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000966	0.00134	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000961	0.00133	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000958	0.00132	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000936	0.00129	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000919	0.00127	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000913	0.00126	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000901	0.00125	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000898	0.00124	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000884	0.00122	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00087	0.0012	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000861	0.00119	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000859	0.00119	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000853	0.00118	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000853	0.00118	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000853	0.00118	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000831	0.00115	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000818	0.00113	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000818	0.00113	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.0008	0.00111	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000793	0.0011	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000789	0.00109	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000781	0.00108	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000776	0.00107	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000768	0.00106	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000764	0.00106	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000758	0.00105	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000758	0.00105	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000755	0.00104	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000743	0.00103	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000726	0.001	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000716	0.00099	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000705	0.000975	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000704	0.000974	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000694	0.00096	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000682	0.000944	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000656	0.000907	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000653	0.000903	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000643	0.000889	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000622	0.000861	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000612	0.000847	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000602	0.000833	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000585	0.000809	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000583	0.000806	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00058	0.000802	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00058	0.000802	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000575	0.000796	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000571	0.000789	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000571	0.000789	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000556	0.000769	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000553	0.000765	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000547	0.000757	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000542	0.00075	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000539	0.000746	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000535	0.00074	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000531	0.000735	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00053	0.000734	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000523	0.000723	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000522	0.000722	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000514	0.000711	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000483	0.000668	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000482	0.000666	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000475	0.000657	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000462	0.000638	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000446	0.000617	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000439	0.000607	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000429	0.000594	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000423	0.000585	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000416	0.000576	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	0.00041	0.000567	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000372	0.000514	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000369	0.00051	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000363	0.000503	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000363	0.000502	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000358	0.000495	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00033	0.000457	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000328	0.000454	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000323	0.000447	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00032	0.000443	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000314	0.000434	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000309	0.000427	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000285	0.000394	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000253	0.00035	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	0.00025	0.000345	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000249	0.000344	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	0.000243	0.000336	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00022	0.000304	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	0.000219	0.000303	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000218	0.000301	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000214	0.000296	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000195	0.00027	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000149	0.000207	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000147	0.000203	CbGpPWpGaD
